The global single-use pump market size was valued at USD 387.3 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 15.92% from 2023 to 2030. The increasing need for single-use pumps across numerous applications as well as the expanding number of biopharmaceutical businesses is driving the market expansion. Furthermore, rising demand for sterile disposable products is projected to fuel the market growth. The COVID-19 pandemic prompted the pharmaceutical sector to rapidly ramp up manufacturing. Increased FDA approvals for biologics have increased biopharmaceutical development, especially within North America & Asia. With a surge in biopharmaceuticals demand expected over the next 5 to 7 years, demand for single-use solutions, such as bioreactors, pumps, mixers, connectors, tubing, and consumables, of instruments is likely to grow.
A rise in the geriatric population and the number of ailments has resulted in an upsurge in pharmaceutical demand. Since the pharmaceutical sector makes substantial use of single-use technology, the requirement for single-use pumps is predicted to rise. Furthermore, increased disposable income has encouraged the rise of the food & beverage and cosmetics industries. With the increasing usage of single-use pumps in the food & beverage and cosmetic industries, along with the chemical industry, the market is expected to flourish during the forecast period. Over the projected period, the market is expected to be driven by increased spending on medication development and discovery.
Single-use pumps are utilized in the pharmaceutical & medical industries to create biological as well as medicinal products, process botanical medications and herbs, separate active medicinal ingredients, and create pharmaceutical products in a variety of forms for internal and external use. According to a report published by the Pharmaceutical Research & Manufacturers of America (PhRMA) in September 2021, biopharmaceutical businesses invested over one trillion dollars in R&D in the previous decade. With increased investments, the R&D as well as the manufacturing sector is projected to bolster, thus creating huge opportunities for bioprocessing instrument manufacturers including single-use pumps.
Rising company investments in constructing single-use pump units and introducing equipment & consumables are also driving the market expansion over the forecast period. For instance, in July 2021, Quattroflow, a subsidiary of PSG & Dover, expanded its capacity to produce components for single-use quaternary diaphragm pumps by building a new ISO Class 7 facility in Duisburg, Germany. It will contribute to meeting the rising demand from consumers for single-use pump products utilized in the manufacture of biologics, medicines, and vaccines. To assure product homogeneity, the new facility functions independently of the present one while adhering to the same assembly methods. All such factors contribute to market growth.
The equipment segment held the largest share of 74.67% of the global revenue in 2022. The segment is also projected to exhibit a higher CAGR of 16.17% from 2023 to 2030. This is primarily attributed to factors, such as the increasing adoption of single-use systems and technologies in pharmaceutical & biotech companies due to benefits, such as lower initial investment and R&D costs, low costs for labor & supplies, growing demand for biologics, and rising demand for single-use pumps among end-users.
Furthermore, the governments have invested heavily in the development of COVID-19 vaccines, treatments, and diagnostic tests. This, in turn, is projected to fuel the demand for single-use pumps, thereby driving the growth of the overall market. For example, in March 2020, the Canadian government funded CAD 275 million (USD 205.92 million) for COVID-19 research and development initiatives, such as diagnostics, antivirals, vaccines, & clinical trials.
The Polypropylene (PP) pump segment held the largest share of 52.24% of the global revenue in 2022. A PP pump is composed of polypropylene, a thermoplastic polymer. Because of its resistance to heat, chemicals, and corrosion, this type of pump is frequently used in the medical & biopharmaceutical industries. Thus, the high demand and usage of PP pumps will contribute to the segment's continued expansion. The Polyethylene (PE) pump segment is expected to grow at the fastest CAGR of 16.44% from 2023 to 2030.
PE pump built from polyethylene has high corrosion resistance to hostile liquids and chemicals. It is frequently utilized in biopharmaceutical, medical, manufacturing sectors, and consumer goods industries. Furthermore, while there are numerous material alternatives, polyethylene is one of the most extensively used. Thus, the growing need for polyethylene in the single-use pump sector is expected to boost market expansion in the coming years.
The biopharmaceutical & pharmaceutical companies segment held the largest share of 42.09% of the global revenue in 2022. The majority of popular biopharmaceutical manufacturing techniques necessitate the handling, transporting, processing, and purifying of large-molecule pharmaceuticals produced by living cells. These operations, which are carried out with materials in a liquid phase, necessitate the use of pumping technologies capable of providing volumetric consistency along with accuracy, adequate pressures & flow rates, and material compatibility. Thus, it will increase the adoption of single-use pumps in biopharmaceutical & pharmaceutical companies and further boost the market growth.
In addition, products offered by major companies are also boosting market growth. For instance, in May 2019, Quattroflow announced the addition of the innovative QF30SU Single-Use Diaphragm Pump to its portfolio of single-use pumps. In November 2022, the company also launched an advanced QF5kSU Quaternary Diaphragm Pumps. The continuous development of novel products by manufacturers and their increasing adoption is likely to propel market growth. The academic and research institutes segment is also projected to grow at a significant growth rate of 15.78% from 2023 to 2030. Growing research on novel products, development of analytical technologies, and growing integration of single-use pumps in bioprocessing research is likely to create a demand for single-use pumps, thus pushing the segmental growth.
North America dominated the global market in 2022 and accounted for the largest share of 40.37% in 2022. This large share can be attributed to several factors including the availability of various major manufacturers, the cost-effectiveness of single-use pumps, increased process efficiency, increased sterility & risk mitigation along with regulatory compliance with stringent regulatory requirements in North America. On the other hand, Asia Pacific is experiencing a massive shift in the bioprocessing market space, and the region is projected to grow at the fastest CAGR of 16.79% from 2023 to 2030.
The market growth in the region is mainly driven by increasing industrialization in sectors, such as pharmaceuticals, food processing, and biotechnology. There has been a rapid growth of the pharma and biotech industries in this region. As these industries require high-quality standards and strict regulations, single-use pumps offer benefits, such as sterility assurance, rapid changeovers, and ease of use. Moreover, many companies in the Asia-Pacific region focus on cost optimization in their manufacturing processes. Single-use pumps offer a perfect solution to reduce cost while still maintaining the highest quality standard. Considering these factors, many companies are encouraged to switch to single-use pumps, thus pushing the market growth in the region.
The market is witnessing growth in investments along with key players engaged in strategic initiatives to maintain their industry presence. For instance, in April 2023, LJ Star announced the major investment in Alphinity’s single-use polymorphic pump technology-based product PIXER. This enables LJ Star to diversify its portfolio and participate in new disruptive products in the industry. Some of the prominent players in the global single-use pump market include:
Dover Corp.
Spirax-Sarco Engineering plc.
Colly Flowtech
Levitronix
PumpCell
Fluid Flow Products, Inc.
PerfuseCell A/S
ALMATECHNIK AG
ESI Technologies Ltd.
Avantor Inc.
Report Attribute |
Details |
Market size value in 2023 |
USD 444.1 million |
Revenue forecast in 2030 |
USD 1249.1 million |
Growth rate |
CAGR of 15.92% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, material, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; Germany; UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Mexico, Argentina; South Africa; Saudi Arabia, UAE; Kuwait |
Key companies profiled |
Dover Corp.; Spirax-Sarco Engineering plc; Colly Flowtech; Levitronix; PumpCell; Fluid Flow Products, Inc.; PerfuseCell A/S; ALMATECHNIK AG; ESI Technologies Ltd.; Avantor Inc. |
Customization scope |
Free report customization (equivalent to up to 8 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the single-use pump market based on product, material, end-use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Equipment
Peristaltic pumps
Quaternary diaphragm pump
Centrifugal pumps
Others
Accessories
Material Outlook (Revenue, USD Million, 2018 - 2030)
Polypropylene (PP) Pumps
Polyethylene (PE) Pumps
Others
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Biopharmaceutical & Pharmaceutical Companies
CROs & CMOs
Academic & Research Institutes
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. The global single-use pump market size was estimated at USD 387.3 million in 2022 and is expected to reach USD 444.1 million in 2023.
b. The global single-use pump market is expected to grow at a compound annual growth rate of 15.92% from 2023 to 2030 to reach USD 1,249.1 million by 2030.
b. North America dominated the single-use pump market with a share of 40.37% in 2022. This is attributable to the availability of various major manufacturers, the launch of new & technologically advanced devices, and favorable reimbursement regulations.
b. Some key players operating in the single-use pump market include Dover Corporation, Spirax-Sarco Engineering plc., COLLY FLOWTECH, Levitronix, PumpCell, FLUID FLOW PRODUCTS, INC., PerfuseCell A/S, ALMATECHNIK AG, ESI Technologies Ltd, Avantor Inc.
b. The increasing need for single-use pumps across numerous applications, as well as the expanding number of biopharmaceutical businesses, are driving the expansion of this market. Furthermore, rising demand for sterile along with disposable products is projected to fuel the expansion of this market.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."